Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Bellinger, Frederick P ^a   Bellinger, Miyoko T ^a   Seale, Lucia A ^a   Takemoto, Andrea S ^a   Raman, Arjun V ^a   Miki, Takanori ^d   Manning Boǧ, Amy B ^e   Berry, Marla J ^a   White, Lon R ^b   Ross, G Webster ^b,c  

^a UNIVERSITY OF HAWAII   (United States)

^b KUAKINI MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d KAGAWA UNIVERSITY   (Japan)

^e SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROMELANIN; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

ARTICLE; AUTOPSY; CELL DENSITY; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DYSTROPHIC AXON; DYSTROPHY; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NERVE FIBER; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN LOCALIZATION; PUTAMEN; SUBSTANTIA NIGRA; UPREGULATION;

EID: 78651550615     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-8     Document Type: Article

References (29)

1. Parkinson's disease - redox mechanisms. JD Adam (Pubitemid 32427909)
2. Dopaminergic neurons. SJ Chinta JK Andersen, Int J Biochem Cell Biol 2005 37 942 946 10.1016/j.biocel.2004.09.009 15743669 (Pubitemid 40311737)
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. GM Halliday A Ophof M Broe PH Jensen E Kettle H Fedorow MI Cartwright FM Griffiths CE Shepherd KL Double, Brain 2005 128 2654 2664 10.1093/brain/awh584 16000336 (Pubitemid 41552949)
4. Aging of the nigrostriatal system in the squirrel monkey. AL McCormack DA Di Monte K Delfani I Irwin LE DeLanney WJ Langston AM Janson, J Comp Neurol 2004 471 387 395 10.1002/cne.20036 15022260 (Pubitemid 38401739)
5. Increased dopamine peroxidation in postmortem Parkinsonian brain. A De Iuliis AP Burlina R Boschetto P Zambenedetti P Arslan L Galzigna, Biochim Biophys Acta 2002 1573 63 67 12383943 (Pubitemid 35279789)
6. The glutathione peroxidases. JR Arthur, Cell Mol Life Sci 2000 57 1825 1835 10.1007/PL00000664 11215509 (Pubitemid 32102578)
7. Regulation and function of selenoproteins in human disease. FP Bellinger AV Raman MA Reeves MJ Berry, Biochem J 2009 422 11 22 10.1042/BJ20090219 19627257
8. Selenium and selenoproteins in the brain and brain diseases. J Chen MJ Berry, J Neurochem 2003 86 1 12 10.1046/j.1471-4159.2003.01854.x 12807419 (Pubitemid 36753840)
9. Glutathione and Parkinson's disease: is this the elephant in the room? GD Zeevalk R Razmpour LP Bernard, Biomed Pharmacother 2008 62 236 249 10.1016/j.biopha.2008.01.017 18400456 (Pubitemid 351626446)
10. Brain peroxidase and catalase in Parkinson disease. LM Ambani MH Van Woert S Murphy, Arch Neurol 1975 32 114 118 1122174
11. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. JC Bensadoun O Mirochnitchenko M Inouye P Aebischer AD Zurn, Eur J Neurosci 1998 10 3231 3236 10.1046/j.1460-9568.1998.00345.x 9786216 (Pubitemid 29070619)
12. Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. JL Ridet JC Bensadoun N Deglon P Aebischer AD Zurn, Neurobiol Dis 2006 21 29 34 10.1016/j.nbd.2005.06.003 16023352 (Pubitemid 41817302)
13. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. JH Power PC Blumbergs, Acta Neuropathol 2009 117 63 73 10.1007/s00401-008-0438-3 18853169
14. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. H Imai F Hirao T Sakamoto K Sekine Y Mizukura M Saito T Kitamoto M Hayasaka K Hanaoka Y Nakagawa, Biochem Biophys Res Commun 2003 305 278 286 10.1016/S0006-291X(03)00734-4 12745070 (Pubitemid 36555464)
15. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. LJ Yant Q Ran L Rao H Van Remmen T Shibatani JG Belter L Motta A Richardson TA Prolla, Free Radic Biol Med 2003 34 496 502 10.1016/S0891-5849(02)01360-6 12566075 (Pubitemid 36140174)
16. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. A Seiler M Schneider H Forster S Roth EK Wirth C Culmsee N Plesnila E Kremmer O Radmark W Wurst,, et al. Cell Metab 2008 8 237 248 10.1016/j.cmet.2008.07.005 18762024
17. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. MP van der Brug J Blackinton J Chandran LY Hao A Lal K Mazan-Mamczarz J Martindale C Xie R Ahmad KJ Thomas,, et al. Proc Natl Acad Sci USA 2008 105 10244 10249 10.1073/pnas.0708518105 18626009
18. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. J Blackinton R Kumaran MP van der Brug R Ahmad L Olson D Galter A Lees R Bandopadhyay MR Cookson, Neurosci Lett 2009 452 8 11 10.1016/j.neulet.2008.12.053 19146923
19. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. GW Ross H Petrovitch RD Abbott J Nelson W Markesbery D Davis J Hardman L Launer K Masaki CM Tanner LR White, Ann Neurol 2004 56 532 539 10.1002/ana.20226 15389895 (Pubitemid 39319343)
20. Glutathione peroxidases and redox-regulated transcription factors. R Brigelius-Flohe, Biol Chem 2006 387 1329 1335 10.1515/BC.2006.166 17081103 (Pubitemid 44691411)
21. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. D Sulzer J Bogulavsky KE Larsen G Behr E Karatekin MH Kleinman N Turro D Krantz RH Edwards LA Greene L Zecca, Proc Natl Acad Sci USA 2000 97 11869 11874 10.1073/pnas.97.22.11869 11050221
22. The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion. J Smythies A De Iuliis L Zanatta L Galzigna, Neurotox Res 2002 4 77 81 10.1080/10298420290007655 12826496 (Pubitemid 34285048)
23. The oxidative metabolism of catecholamines in the brain: a review. J Smythies L Galzigna, Biochim Biophys Acta 1998 1380 159 162 9565677 (Pubitemid 28177547)
24. "Subcellular proteomics" of neuromelanin granules isolated from the human brain. F Tribl M Gerlach K Marcus E Asan T Tatschner T Arzberger HE Meyer G Bringmann P Riederer, Mol Cell Proteomics 2005 4 945 957 10.1074/mcp.M400117-MCP200 15851778 (Pubitemid 41309152)
25. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease. TG Hastings, J Bioenerg Biomembr 2009 41 469 472 10.1007/s10863-009-9257-z 19967436
26. Influence of neuromelanin on oxidative pathways within the human substantia nigra. KL Double D Ben-Shachar MB Youdim L Zecca P Riederer M Gerlach, Neurotoxicol Teratol 2002 24 621 628 10.1016/S0892-0362(02)00218-0 12200193 (Pubitemid 35013523)
27. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. L White H Petrovitch GW Ross KH Masaki RD Abbott EL Teng BL Rodriguez PL Blanchette RJ Havlik G Wergowske,, et al. Jama 1996 276 955 960 10.1001/jama.276.12.955 8805729 (Pubitemid 26318224)
28. Association of selenoprotein P with Alzheimer's pathology in human cortex. FP Bellinger QP He MT Bellinger Y Lin AV Raman LR White MJ Berry, J Alzheimers Dis 2008 15 465 472 18997300
29. Age and gender effects on microglia and astrocyte numbers in brains of mice. PR Mouton JM Long DL Lei V Howard M Jucker ME Calhoun DK Ingram, Brain Res 2002 956 30 35 10.1016/S0006-8993(02)03475-3 12426043 (Pubitemid 35335553)